Luz Martín-Carbonero

10PUBLICATIONS
78CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCardiology (incl. cardiovascular diseases)Medical virologyConcurrency theoryGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Jun 01, 2026
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.

|Feb 10, 2026
Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.

María De Lagarde, Rosa De Miguel, Mayra A Sigcha

|Dec 30, 2025
IFNL4-rs12979860 CC genotype predisposes to accelerated terminal exhaustion and senescence in HIV/HCV-chronic infection.

Sonia Arca-Lafuente, Violeta Lara-Aguilar, Manuel Llamas-Adán

|Mar 28, 2025
Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study.

Ignacio Pérez-Valero, Diana Corona Mata, Angela Camacho Espejo

|Mar 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

Alejandro de Gea-Grela, Rafael Micán, Rosa de Miguel

Pageof 2

Frequent Collaborators

4 joint publications

Pablo Ryan

4 joint publications

Ignacio De Los Santos

3 joint publications

Jose Ramon Arribas

3 joint publications

Amanda Fernández-Rodríguez